We are a pharmaceutical and nutritional supplement company focusing on the research and development of proprietary drugs including our anti-cancer compound Adva-27a, and anti-coronavirus lead compound, SBFM-PL4.
Last Closing Price
February 15, 2022
AEGIS CAPITAL CORP.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Sunshine Biopharma, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277